Recent Finacing
Recent Raise
EpiBiome engineers precision microbiome-based therapeutics and platform technologies to develop FDA-approvable, non–small-molecule treatments for infectious diseases in humans and agriculture, initially targeting bovine mastitis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors